Medizinische Universität Graz - Research portal

• Go directly to the nagivation.
• Go directly to the content.

• Print view.
• German.
• Contact.
• Data entry.
• Start.
• Open Access.

Effects of eplerenone on parathyroid hormone levels and bone mineral density in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial (EPATH: Eplerenone in hyperPAraTHyroidism Study)

Project Leader:

Tomaschitz Andreas

Duration:

01.06.2012-30.06.2015

Programme:

Jubiläumsfonds (ÖNB)

Type of Research

clinical trial

Staff

Tomaschitz, Andreas, Project Leader

MUG Research Units

Division of Cardiology

Funded by

Österreichische Nationalbank (Jubiläumsfonds), Otto Wagner Platz 3, A-1090 Wien, Austria